Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1984 Jan;14(1):61-71.
doi: 10.1007/BF02469605.

The role of the spleen in tumor bearing host: I. Characterization of spleen cells in tumor-bearing mice

Comparative Study

The role of the spleen in tumor bearing host: I. Characterization of spleen cells in tumor-bearing mice

H Yamagishi et al. Jpn J Surg. 1984 Jan.

Abstract

Morphologic changes of the spleen and dynamic changes of biologic activity of spleen cells from C3H/HeJ mice bearing methylcholanthrene induced fibrosarcoma (MCA-F) were investigated in different stages of tumor growth, using local adoptive transfer assay (LATA). The spleen size, weight and the number of spleen cells increased with the tumor growth. In early and late stages of tumor growth, tumor-bearing mice possessed non-specific tumor-enhancing cells which were radioresistant (700 rads), phagocytic and adherent, suggesting that they were macrophages. On the other hand, in middle stages of tumorgenesis, tumor-bearing mice possessed specific cytotoxic cells which were radiosensitive (700 rads) and anti-Thy 1.2 serum positive, suggesting that they were T-cells. Thus, the appearance of tumor-enhancing cells was earlier than cytotoxic cells in MCA-F bearing host, and the balance of tumor-enhancing and cytotoxic cells may influence the tumor outgrowth in different stages of tumorgenesis. The spleen serves as a reservoir of factors which either abrogate cell mediated resistance or stimulate neoplastic growth, or as the source of cytotoxic cells, at certain times of tumor burden.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Surg Res. 1979 Apr;26(4):392-9 - PubMed
    1. Int J Cancer. 1972 Nov;10(3):581-8 - PubMed
    1. J Immunol. 1975 May;114(5):1554-6 - PubMed
    1. J Natl Cancer Inst. 1976 Dec;57(6):1241-7 - PubMed
    1. J Immunol. 1976 May;116(5):1342-6 - PubMed

Publication types